---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-001509"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T19:32:12.440184+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv adopts amended bylaws adding advance notice, supermajority vote requirement

## Summary
- Advance notice bylaw established as exclusive means for stockholder proposals and nominations.
- Stockholder action by written consent requires delivery within 60 days and proper method per DGCL.
- Board now solely sets board size; vacancies filled by remaining directors.
- Stockholder amendments to bylaws require 66 2/3% supermajority vote.
- Indemnification provisions added for directors, officers, employees, and agents.

## SEC filing metadata
- accession: 0001654954-23-001509
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495423001509/0001654954-23-001509-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495423001509/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-001509
- JSON: https://secwatch.observer/filing/0001654954-23-001509.json
- Plain text: https://secwatch.observer/filing/0001654954-23-001509.txt

## Key facts
- Governance Changes
  Pharma-Bio Serv, Inc.: Adopted amended and restated bylaws including advance notice for stockholder business, revised stockholder action by written consent, board size and vacancy filling, indemnification, and supermajority vote for bylaw amendments (effective 2023-02-08).
  - Change: bylaw amendment
  - Effective: 2023-02-08
  source text: On February 8, 2023, the Board of Directors (the “Board”) of Pharma-Bio Serv, Inc. (the “Company”) adopted the Amended and Restated ByLaws of the Company (the "Amended ByLaws"), effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495423001509/0001654954-23-001509-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.